ADULT SOLID TUMOR
Clinical trials for ADULT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADULT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADULT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody combo aims to boost lung cancer treatment response
Disease control Recruiting nowThis study tests whether adding the experimental drug visugromab to standard chemotherapy and immunotherapy can shrink tumors better than placebo in people with newly diagnosed metastatic non-squamous non-small cell lung cancer. About 107 adults who have not had prior treatment f…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated May 26, 2026 06:35 UTC
-
New drug cocktail aims to shrink lung tumors when standard care fails
Disease control Recruiting nowThis study tests a new drug called visugromab combined with nivolumab and/or docetaxel in people with advanced non-squamous lung cancer that has worsened after initial treatment. About 131 participants will receive different combinations to see if the new mix shrinks tumors bette…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New pill targets Hard-to-Treat cancers with specific gene mutation
Disease control Recruiting nowThis early-phase study tests a new oral drug, DO-2, in adults with advanced solid tumors (like lung cancer) that have a specific MET gene change and no standard treatment options left. The main goal is to check the drug's safety and find the right dose. About 55 participants will…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE1 • Sponsor: DeuterOncology • Aim: Disease control
Last updated May 04, 2026 16:17 UTC